AADI - Aadi Bioscience GAAP EPS of -$0.67 misses by $0.07 revenue of $6.2M misses by $0.11M
2023-08-09 08:06:37 ET
- Aadi Bioscience press release ( NASDAQ: AADI ): Q2 GAAP EPS of -$0.67 misses by $0.07 .
- Revenue of $6.2M (+80.2% Y/Y) misses by $0.11M .
- Cash, cash equivalents and short-term investments as of June 30, 2023, were $134.9 million as compared to $172.6 million as of December 31, 2022, which is expected to fund operations into 2025 based on current plans.
For further details see:
Aadi Bioscience GAAP EPS of -$0.67 misses by $0.07, revenue of $6.2M misses by $0.11M